Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-17 4:32 pm Purchase | 2023-01-12 | 13D | ACADIA PHARMACEUTICALS INC ACAD | Baker Bros. Advisors LP | 42,306,789 26.100% | 1,138,932![]() (+2.77%) | Filing History |
| 2022-12-12 4:49 pm Sale | 2022-11-30 | 13G | AMARIN CORP PLC SPONSORED ADR AMRN | Baker Bros. Advisors LP | 0 0.000% | -1,064,659![]() (Position Closed) | Filing History |
| 2022-11-10 4:35 pm Sale | 2022-10-31 | 13G | OTONOMY INC OTIC | Baker Bros. Advisors LP | 3,448,263 6.100% | -4,396,429![]() (-56.04%) | Filing History |
| 2022-10-07 4:20 pm Purchase | 2022-09-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Baker Bros. Advisors LP | 6,062,702 10.900% | 2,199,463![]() (+56.93%) | Filing History |
| 2022-07-20 5:12 pm Purchase | 2022-07-15 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | Baker Bros. Advisors LP | 4,685,690 9.930% | 1,333,333![]() (+39.77%) | Filing History |
| 2022-06-13 5:27 pm Purchase | 2022-06-07 | 13D | TALIS BIOMEDICAL CORP COM TLIS | Baker Bros. Advisors LP | 2,500,336 66.400% | 4,389![]() (+0.18%) | Filing History |
| 2022-06-13 5:23 pm Purchase | 2022-06-08 | 13D | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Baker Bros. Advisors LP | 2,348,967 24.980% | 1,232,500![]() (+110.39%) | Filing History |
| 2022-06-06 5:10 pm Purchase | 2022-06-03 | 13D | KODIAK SCIENCES INC KOD | Baker Bros. Advisors LP | 17,353,846 33.400% | 922,755![]() (+5.62%) | Filing History |
| 2022-05-18 5:23 pm Purchase | 2022-05-16 | 13D | KODIAK SCIENCES INC KOD | Baker Bros. Advisors LP | 16,431,091 31.600% | 865,023![]() (+5.56%) | Filing History |
| 2022-05-12 4:45 pm Purchase | 2022-05-10 | 13D | TSCAN THERAPEUTICS INC TCRX | Baker Bros. Advisors LP | 2,784,792 14.700% | 1,359,792![]() (+95.42%) | Filing History |
| 2022-04-05 5:15 pm Purchase | 2022-03-29 | 13D | IGM BIOSCIENCES INC IGMS | Baker Bros. Advisors LP | 3,169,894 11.600% | 12,110![]() (+0.38%) | Filing History |
| 2022-03-10 5:20 pm Purchase | 2022-03-08 | 13D | INCYTE CORPORATION INCY | Baker Bros. Advisors LP | 36,634,354 16.500% | 1,417,736![]() (+4.03%) | Filing History |
| 2022-03-10 4:40 pm Sale | 2022-03-08 | 13D | SEATTLE GENETICS INC SGEN | Baker Bros. Advisors LP | 47,223,608 25.700% | -394,895![]() (-0.83%) | Filing History |
| 2022-02-14 4:20 pm Purchase | 2022-02-10 | 13D | INCYTE CORPORATION INCY | Baker Bros. Advisors LP | 35,216,618 15.900% | 2,692,198![]() (+8.28%) | Filing History |
| 2022-02-14 4:17 pm Sale | 2021-12-31 | 13G | INVITAE CORP COM NVTAQ | Baker Bros. Advisors LP | 9,873,488 4.400% | -5,900,607![]() (-37.41%) | Filing History |
| 2022-02-14 4:17 pm Purchase | 2021-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Baker Bros. Advisors LP | 3,863,239 7.700% | 1,548,366![]() (+66.89%) | Filing History |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | OTONOMY INC OTIC | Baker Bros. Advisors LP | 7,844,692 13.800% | 624,618![]() (+8.65%) | Filing History |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | ZYMEWORKS INC ZYME | Baker Bros. Advisors LP | 4,977,296 9.990% | 67,486![]() (+1.37%) | Filing History |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Baker Bros. Advisors LP | 64,917,601 9.990% | 25,285,672![]() (+63.80%) | Filing History |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | VERASTEM, INC. VSTM | Baker Bros. Advisors LP | 1,790,969 11.800% | 233,828![]() (+15.02%) | Filing History |

